Hubbry Logo
HyperthermiaHyperthermiaMain
Open search
Hyperthermia
Community hub
Hyperthermia
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Hyperthermia
Hyperthermia
Hyperthermia
View on Wikipedia
from Wikipedia

Hyperthermia
Other namesOverheating
An analog medical thermometer showing a temperature of 38.7 °C (101.7 °F)
SpecialtyCritical care medicine
SymptomsLack of perspiration, confusion, delirium, decreased blood pressure, increased heart rate and respiration rate, symptoms of dehydration
ComplicationsOrgan failure, unconsciousness
CausesHeat stroke[1]
Risk factorsExposure to hot and/or humid environments, physical exertion, wearing personal protective equipment that covers the body, heatwaves
Diagnostic methodBased on symptoms or body temperature above 37.7 °C (99.9 °F)[2]
Differential diagnosisFever[3]
PreventionMaintaining a moderate temperature, regular hydration, taking regular breaks
TreatmentMild: Staying away from hot environments, rehydrating oneself, mechanical cooling, use of a dehumidifier
Severe: intravenous hydration, gastric lavage with iced saline, hemodialysis, immersing in ice water

Hyperthermia, also known as overheating, is a condition in which an individual's body temperature is elevated beyond normal due to failed thermoregulation. The person's body produces or absorbs more heat than it dissipates. According to the International Emergency Medicine Education Project, severe hyperthermia (body temperature elevation of beyond 40 °C (104 °F)) "becomes a medical emergency requiring immediate treatment to prevent disability or death".[4] Almost half a million deaths are recorded every year from hyperthermia.[5]

The most common causes include heat stroke and adverse reactions to drugs. Heat stroke is an acute temperature elevation caused by exposure to excessive heat, or combination of heat and humidity, that overwhelms the heat-regulating mechanisms of the body. The latter is a relatively rare side effect of many drugs, particularly those that affect the central nervous system. Malignant hyperthermia is a rare complication of some types of general anesthesia. Hyperthermia can also be caused by a traumatic brain injury.[6][7][8]

Hyperthermia differs from fever in that the body's temperature set point remains unchanged. The opposite is hypothermia, which occurs when the temperature drops below that required to maintain normal metabolism. The term is from Greek ὑπέρ, hyper, meaning "above", and θέρμος, thermos, meaning "heat".

The highest recorded body temperature recorded in a patient who survived hyperthermia is 46.5 °C (115.7 °F), measured on 10 July 1980 from a man who had been admitted to hospital for serious heat stroke.[9]

Classification

[edit]
Temperature classification
Core (rectal, esophageal, etc.)
Hypothermia <35.0 °C (95.0 °F)[10]
Normal 36.5–37.5 °C (97.7–99.5 °F)[11][12]
Fever >37.5 or 38.3 °C (99.5 or 100.9 °F)[3][13]
Hyperthermia >37.5 or 38.3 °C (99.5 or 100.9 °F)[3][13]
Hyperpyrexia >40.0 or 41.0 °C (104.0 or 105.8 °F)[14][15]
Note: The difference between fever and hyperthermia is the underlying mechanism. Different sources have different cut-offs for fever, hyperthermia and hyperpyrexia.

In humans, hyperthermia is defined as a temperature greater than 37.5–38.3 °C (99.5–100.9 °F), depending on the reference used, that occurs without a change in the body's temperature set point.[3][13]

The normal human body temperature can be as high as 37.7 °C (99.9 °F) in the late afternoon.[2] Hyperthermia requires an elevation from the temperature that would otherwise be expected. Such elevations range from mild to extreme; body temperatures above 40 °C (104 °F) can be life-threatening.

Signs and symptoms

[edit]

An early stage of hyperthermia can be "heat exhaustion" (or "heat prostration" or "heat stress"), whose symptoms can include heavy sweating, rapid breathing and a fast, weak pulse. If the condition progresses to heat stroke, then hot, dry skin is typical[2] as blood vessels dilate in an attempt to increase heat loss. An inability to cool the body through perspiration may cause dry skin. Hyperthermia from neurological disease may include little or no sweating, cardiovascular problems, and confusion or delirium.

Other signs and symptoms vary. Accompanying dehydration can produce nausea, vomiting, headaches, and low blood pressure and the latter can lead to fainting or dizziness, especially if the standing position is assumed quickly.

In severe heat stroke, confusion and aggressive behavior may be observed. Heart rate and respiration rate will increase (tachycardia and tachypnea) as blood pressure drops and the heart attempts to maintain adequate circulation. The decrease in blood pressure can then cause blood vessels to contract reflexively, resulting in a pale or bluish skin color in advanced cases. Young children, in particular, may have seizures. Eventually, organ failure, unconsciousness and death will result.

Causes

[edit]

Heat stroke occurs when thermoregulation is overwhelmed by a combination of excessive metabolic production of heat (exertion), excessive environmental heat, and insufficient or impaired heat loss, resulting in an abnormally high body temperature.[2] In severe cases, temperatures can exceed 40 °C (104 °F).[16] Heat stroke may be non-exertional (classic) or exertional.

Exertional

[edit]

Significant physical exertion in hot conditions can generate heat beyond the ability to cool, because, in addition to the heat, humidity of the environment may reduce the efficiency of the body's normal cooling mechanisms.[2] Human heat-loss mechanisms are limited primarily to sweating (which dissipates heat by evaporation, assuming sufficiently low humidity) and vasodilation of skin vessels (which dissipates heat by convection proportional to the temperature difference between the body and its surroundings, according to Newton's law of cooling). Other factors, such as insufficient water intake, consuming alcohol, or lack of air conditioning, can worsen the problem.

The increase in body temperature that results from a breakdown in thermoregulation affects the body biochemically. Enzymes involved in metabolic pathways within the body such as cellular respiration fail to work effectively at higher temperatures, and further increases can lead them to denature, reducing their ability to catalyse essential chemical reactions. This loss of enzymatic control affects the functioning of major organs with high energy demands such as the heart and brain.[17] Loss of fluid and electrolytes cause heat cramps – slow muscular contraction and severe muscular spasm lasting between one and three minutes. Almost all cases of heat cramps involve vigorous physical exertion. Body temperature may remain normal or a little higher than normal and cramps are concentrated in heavily used muscles.

Situational

[edit]
Chart showing number of heat-related deaths by date of occurrence and race of decedent versus heat index, Chicago, July 11–27, 1995

Situational heat stroke occurs in the absence of exertion. It mostly affects the young and elderly. In the elderly in particular, it can be precipitated by medications that reduce vasodilation and sweating, such as anticholinergic drugs, antihistamines, and diuretics.[2] In this situation, the body's tolerance for high environmental temperature may be insufficient, even at rest.

Heat waves are often followed by a rise in the death rate, and these 'classical hyperthermia' deaths typically involve the elderly and infirm. This is partly because thermoregulation involves cardiovascular, respiratory and renal systems which may be inadequate for the additional stress because of the existing burden of aging and disease, further compromised by medications. During the July 1995 heatwave in Chicago, there were at least 700 heat-related deaths. The strongest risk factors were being confined to bed, and living alone, while the risk was reduced for those with working air conditioners and those with access to transportation. Even then, reported deaths may be underestimated as diagnosis can be mis-classified as stroke or heart attack.[18]

Drugs

[edit]

Some drugs cause excessive internal heat production.[2] The rate of drug-induced hyperthermia is higher where use of these drugs is higher.[2]

Personal protective equipment

[edit]

Those working in industry, in the military, or as first responders may be required to wear personal protective equipment (PPE) against hazards such as chemical agents, gases, fire, small arms and improvised explosive devices (IEDs). PPE includes a range of hazmat suits, firefighting turnout gear, body armor and bomb suits, among others. Depending on design, the wearer may be encapsulated in a microclimate,[23] due to an increase in thermal resistance and decrease in vapor permeability. As physical work is performed, the body's natural thermoregulation (i.e. sweating) becomes ineffective. This is compounded by increased work rates, high ambient temperature and humidity levels, and direct exposure to the sun. The net effect is that desired protection from some environmental threats inadvertently increases the threat of heat stress.

The effect of PPE on hyperthermia has been noted in fighting the 2014 Ebola virus epidemic in Western Africa. Doctors and healthcare workers were only able to work for 40 minutes at a time in their protective suits, fearing heat stroke.[24]

Other

[edit]

Other rare causes of hyperthermia include thyrotoxicosis and an adrenal gland tumor, called pheochromocytoma, both of which can cause increased heat production.[2] Damage to the central nervous system from brain hemorrhage, traumatic brain injury, status epilepticus, and other kinds of injury to the hypothalamus can also cause hyperthermia.[2]

Pathophysiology

[edit]
A summary of the differences between hyperthermia, hypothermia, and fever.
Hyperthermia: Characterized on the left. Normal body temperature (thermoregulatory set-point) is shown in green, while the hyperthermic temperature is shown in red. As can be seen, hyperthermia can be considered an increase above the thermoregulatory set-point.
Hypothermia: Characterized in the center: Normal body temperature is shown in green, while hypothermic temperature is shown in blue. As can be seen, hypothermia can be conceptualized as a decrease below the thermoregulatory set-point.
Fever: Characterized on the right: Normal body temperature is shown in green. It reads "New Normal" because the thermoregulatory set-point has risen. This has caused what was the normal body temperature (in blue) to be considered hypothermic.

A fever occurs when the core temperature is set higher, through the action of the pre-optic region of the anterior hypothalamus. For example, in response to a bacterial or viral infection, certain white blood cells within the blood will release pyrogens which have a direct effect on the anterior hypothalamus, causing body temperature to rise, much like raising the temperature setting on a thermostat.

In contrast, hyperthermia occurs when the body temperature rises without a change in the heat control centers.

Some of the gastrointestinal symptoms of acute exertional heatstroke, such as vomiting, diarrhea, and gastrointestinal bleeding, may be caused by barrier dysfunction and subsequent endotoxemia. Ultraendurance athletes have been found to have significantly increased plasma endotoxin levels. Endotoxin stimulates many inflammatory cytokines, which in turn may cause multiorgan dysfunction. Experimentally, monkeys treated with oral antibiotics prior to induction of heat stroke do not become endotoxemic.[25]

There is scientific support for the concept of a temperature set point; that is, maintenance of an optimal temperature for the metabolic processes that life depends on. Nervous activity in the preoptic-anterior hypothalamus of the brain triggers heat losing (sweating, etc.) or heat generating (shivering and muscle contraction, etc.) activities through stimulation of the autonomic nervous system. The pre-optic anterior hypothalamus has been shown to contain warm sensitive, cool sensitive, and temperature insensitive neurons, to determine the body's temperature setpoint. As the temperature that these neurons are exposed to rises above 37 °C (99 °F), the rate of electrical discharge of the warm-sensitive neurons increases progressively. Cold-sensitive neurons increase their rate of electrical discharge progressively below 37 °C (99 °F).[26]

Diagnosis

[edit]

Hyperthermia is generally diagnosed by the combination of unexpectedly high body temperature and a history that supports hyperthermia instead of a fever.[2] Most commonly this means that the elevated temperature has occurred in a hot, humid environment (heat stroke) or in someone taking a drug for which hyperthermia is a known side effect (drug-induced hyperthermia). The presence of signs and symptoms related to hyperthermia syndromes, such as extrapyramidal symptoms characteristic of neuroleptic malignant syndrome, and the absence of signs and symptoms more commonly related to infection-related fevers, are also considered in making the diagnosis.

If fever-reducing drugs lower the body temperature, even if the temperature does not return entirely to normal, then hyperthermia is excluded.[2]

Prevention

[edit]

When ambient temperature is excessive, humans and many other animals cool themselves below ambient by evaporative cooling of sweat (or other aqueous liquid; saliva in dogs, for example); this helps prevent potentially fatal hyperthermia. The effectiveness of evaporative cooling depends upon humidity. Wet-bulb temperature, which takes humidity into account, or more complex calculated quantities such as wet-bulb globe temperature (WBGT), which also takes solar radiation into account, give useful indications of the degree of heat stress and are used by several agencies as the basis for heat-stress prevention guidelines. (Wet-bulb temperature is essentially the lowest skin temperature attainable by evaporative cooling at a given ambient temperature and humidity.)

A sustained wet-bulb temperature exceeding 35 °C (95 °F) is likely to be fatal even to fit and healthy people unclothed in the shade next to a fan; at this temperature, environmental heat gain instead of loss occurs. A 2020 survey of weather station data shows that wet-bulb temperatures have exceeded 31 °C (88 °F) – 33 °C (91 °F) many times across the world, and have exceeded 35 °C (95 °F) multiple times in two stations.[27]

In cases of heat stress caused by physical exertion, hot environments, or protective equipment, prevention or mitigation by frequent rest breaks, careful hydration, and monitoring body temperature should be attempted.[28] However, in situations demanding one is exposed to a hot environment for a prolonged period or must wear protective equipment, a personal cooling system is required as a matter of health and safety. There are a variety of active or passive personal cooling systems;[23] these can be categorized by their power sources and whether they are person- or vehicle-mounted.

Because of the broad variety of operating conditions, these devices must meet specific requirements concerning their rate and duration of cooling, their power source, and their adherence to health and safety regulations. Among other criteria are the user's need for physical mobility and autonomy. For example, active-liquid systems operate by chilling water and circulating it through a garment; the skin surface area is thereby cooled through conduction. This type of system has proven successful in certain military, law enforcement, and industrial applications. Bomb-disposal technicians wearing special suits to protect against improvised explosive devices (IEDs) use a small, ice-based chiller unit that is strapped to one leg; a liquid-circulating garment, usually a vest, is worn over the torso to maintain a safe core body temperature. By contrast, soldiers traveling in combat vehicles can face microclimate temperatures in excess of 65 °C (149 °F) and require a multiple-user, vehicle-powered cooling system with rapid connection capabilities. Requirements for hazmat teams, the medical community, and workers in heavy industry vary further.

Treatment

[edit]

The underlying cause must be removed. Mild hyperthemia caused by exertion on a hot day may be adequately treated through self-care measures, such as increased water consumption and resting in a cool place. Hyperthermia that results from drug exposure requires prompt cessation of that drug, and occasionally the use of other drugs as counter measures.

Antipyretics (e.g., acetaminophen, aspirin, other nonsteroidal anti-inflammatory drugs) have no role in the treatment of heatstroke because antipyretics interrupt the change in the hypothalamic set point caused by pyrogens; they are not expected to work on a healthy hypothalamus that has been overloaded, as in the case of heatstroke. In this situation, antipyretics actually may be harmful in patients who develop hepatic, hematologic, and renal complications because they may aggravate bleeding tendencies.[29]

When body temperature is significantly elevated, mechanical cooling methods are used to remove heat and to restore the body's ability to regulate its own temperatures.[2] Passive cooling techniques, such as resting in a cool, shady area and removing clothing can be applied immediately. Active cooling methods, such as sponging the head, neck, and trunk with cool water, remove heat from the body and thereby speed the body's return to normal temperatures. When methods such as immersion are impractical, misting the body with water and using a fan have also been shown to be effective.[30]

Sitting in a bathtub of tepid or cool water (immersion method) can remove a significant amount of heat in a relatively short period of time. It was once thought that immersion in very cold water is counterproductive, as it causes vasoconstriction in the skin and thereby prevents heat from escaping the body core. However, a British analysis of various studies stated: "this has never been proven experimentally. Indeed, a recent study using normal volunteers has shown that cooling rates were fastest when the coldest water was used."[31] The analysis concluded that iced water immersion is the most-effective cooling technique for exertional heat stroke.[31] No superior cooling method has been found for non-exertional heat stroke.[32] Thus, aggressive ice-water immersion remains the gold standard for life-threatening heat stroke.[33][34]

When the body temperature reaches about 40 °C (104 °F), or if the affected person is unconscious or showing signs of confusion, hyperthermia is considered a medical emergency that requires treatment in a proper medical facility. A cardiopulmonary resuscitation (CPR) may be necessary if the person goes into cardiac arrest (stop of heart beats). Already in a hospital, more aggressive cooling measures are available, including intravenous hydration, gastric lavage with iced saline, and even hemodialysis to cool the blood.[2]

Epidemiology

[edit]

Hyperthermia affects those who are unable to regulate their body heat, mainly due to environmental conditions. The main risk factor for hyperthermia is the lack of ability to sweat. People who are dehydrated or who are older may not produce the sweat they need to regulate their body temperature.[35] High heat conditions can put certain groups at risk for hyperthermia including: physically active individuals, soldiers, construction workers, landscapers and factory workers. Some people that do not have access to cooler living conditions, like people with lower socioeconomic status, may have a difficult time fighting the heat. People are at risk for hyperthermia during high heat and dry conditions, most commonly seen in the summer.

Various cases of different types of hyperthermia have been reported. A research study was published in March 2019 that looked into multiple case reports of drug induced hyperthermia. The study concluded that psychotropic drugs such as anti-psychotics, antidepressants, and anxiolytics were associated with an increased heat-related mortality as opposed to the other drugs researched (anticholinergics, diuretics, cardiovascular agents, etc.).[36] A different study was published in June 2019 that examined the association between hyperthermia in older adults and the temperatures in the United States. Hospitalization records of elderly patients in the US between 1991 and 2006 were analyzed and concluded that cases of hyperthermia were observed to be highest in regions with arid climates. The study discussed finding a disproportionately high number of cases of hyperthermia in early seasonal heat waves indicating that people were not yet practicing proper techniques to stay cool and prevent overheating in the early presence of warm, dry weather.[37]

In urban areas people are at an increased susceptibility to hyperthermia. This is due to a phenomenon called the urban heat island effect.[38] Since the 20th century in the United States, the north-central region (Ohio, Indiana, Illinois, Missouri, Iowa, and Nebraska) was the region with the highest morbidity resulting from hyperthermia. Northeastern states had the next highest. Regions least affected by heat wave-related hyperthermia causing death were Southern and Pacific Coastal states.[39] Northern cities in the United States are at greater risk of hyperthermia during heat waves due to the fact that people tend to have a lower minimum mortality temperature at higher latitudes.[40] In contrast, cities residing in lower latitudes within the continental US typically have higher thresholds for ambient temperatures.[40] In India, hundreds die every year from summer heat waves,[41] including more than 2,500 in the year 2015.[42] Later that same summer, the 2015 Pakistani heat wave killed about 2,000 people.[43] An extreme 2003 European heat wave caused tens of thousands of deaths.[44]

Causes of hyperthermia include dehydration, use of certain medications, using cocaine and amphetamines or excessive alcohol use.[45] Bodily temperatures greater than 37.5–38.3 °C (99.5–100.9 °F) can be diagnosed as a hyperthermic case.[45] As body temperatures increase or excessive body temperatures persist, individuals are at a heightened risk of developing progressive conditions. Greater risk complications of hyperthermia include heat stroke, organ malfunction, organ failure, and death. There are two forms of heat stroke; classical heatstroke and exertional heatstroke. Classical heatstroke occurs from extreme environmental conditions, such as heat waves. Those who are most commonly affected by classical heatstroke are very young, elderly or chronically ill. Exertional heatstroke appears in individuals after vigorous physical activity. Exertional heatstroke is displayed most commonly in healthy 15-50 year old people. Sweating is often present in exertional heatstroke.[46] The associated mortality rate of heatstroke is 40 to 64%.[45]

Research

[edit]

Hyperthermia can also be deliberately induced using drugs or medical devices, and is being studied and applied in clinical routine as a treatment of some kinds of cancer.[47] Research has shown that medically controlled hyperthermia can shrink tumours.[48][49] This occurs when a high body temperature damages cancerous cells by destroying proteins and structures within each cell.[50][48] Hyperthermia has also been researched to investigate whether it causes cancerous tumours to be more prone to radiation as a form of treatment; which as a result has allowed hyperthermia to be used to complement other forms of cancer therapy.[51][48] Various techniques of hyperthermia in the treatment of cancer include local or regional hyperthermia, as well as whole body techniques.[48]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Hyperthermia

View on Grokipedia
from Grokipedia
Hyperthermia is a pathological condition in which the core body temperature rises above the normal range, typically exceeding 40°C (104°F), due to a failure in the body's thermoregulatory mechanisms rather than an intentional elevation of the temperature set point as seen in fever. This elevation occurs when heat gain from environmental exposure, metabolic production, or impaired heat loss surpasses the body's , potentially leading to severe complications such as if untreated. Unlike fever, which is mediated by cytokines and can be beneficial in fighting , hyperthermia is unregulated and often requires immediate intervention to prevent progression to heatstroke or death. The condition encompasses several forms, including environmental hyperthermia from prolonged exposure to high temperatures and humidity, exertional hyperthermia triggered by intense physical activity in hot conditions, and drug-induced hyperthermia associated with substances like amphetamines or anticholinergics that disrupt sweating and vasodilation. A particularly life-threatening variant is malignant hyperthermia, a rare genetic disorder provoked by certain anesthetic agents, causing rapid temperature spikes, muscle rigidity, and rhabdomyolysis. Symptoms commonly include hot, dry skin, rapid heartbeat, confusion, nausea, and seizures, with core temperatures above 105°F (40.6°C) indicating severe cases that demand rapid cooling. Treatment focuses on aggressive cooling methods such as ice packs, cold water immersion, or evaporative cooling, alongside supportive care like fluid resuscitation and monitoring for complications like . Prevention strategies emphasize hydration, to , protective , and avoiding high-risk activities during peak temperatures, particularly for vulnerable populations such as the elderly, children, and those with chronic illnesses. In a distinct medical application, therapeutic hyperthermia involves controlled heating of tissues to 40–45°C (104–113°F) to enhance efficacy, often combined with or , as elevated temperatures selectively damage tumor cells while sparing healthy tissue. This modality, including local, regional, or whole-body approaches, is under investigation for various malignancies but remains experimental in many settings.

Classification and Types

Heat-related disorders, also known as heat illnesses, represent a of conditions arising from the body's failure to adequately dissipate , primarily due to environmental exposure in hot or humid conditions. These disorders range from mild, self-limiting issues to severe, life-threatening emergencies, forming a continuum where early recognition can prevent progression to more critical states. They are distinct from other forms of hyperthermia, such as drug-induced syndromes, as they stem predominantly from exogenous heat stress rather than internal metabolic or pharmacological factors. At the mild end of the spectrum, heat rash (prickly heat or ) develops when ducts become obstructed, preventing evaporation and leading to . It typically manifests as small, itchy red bumps or clear blisters on the skin, often in areas covered by tight clothing or where sweating is profuse, such as the , chest, or . This condition is exacerbated by high humidity and can cause discomfort but rarely elevates core body temperature significantly. Heat cramps involve sudden, painful muscle contractions, most commonly in the legs, arms, or , triggered by excessive sweating that depletes electrolytes like sodium and during strenuous activity in warm environments. The individual's core temperature remains near normal or only mildly elevated (below 102°F or 39°C), and symptoms include intense spasms that may last several minutes, often resolving with rest and hydration but signaling the need to stop exertion to avoid escalation. Progressing further, occurs due to peripheral and blood pooling in the extremities, reducing cerebral blood flow during prolonged standing or sudden rising in hot conditions. Symptoms include , , , and fainting, with normal or slightly elevated body temperature; it is more common in unacclimatized individuals and resolves quickly upon lying down but indicates vulnerability to more severe disorders. Heat exhaustion marks a moderate stage where the body's compensatory mechanisms are overwhelmed, leading to significant fluid and loss. Core temperature typically ranges from 101°F to 104°F (38.3°C to 40°C), accompanied by symptoms such as heavy sweating, , , , , , , muscle cramps, and cool, pale, clammy with a rapid but weak . This condition reflects cardiovascular strain from and heat stress, and without intervention, it can rapidly advance to . The most severe form, , is a characterized by core body temperature exceeding 104°F (40°C), with failure of and dysfunction. It presents with hot, dry skin (or profuse sweating in exertional cases), altered mental status including confusion, , seizures, or , rapid , and potential multi-organ failure due to cellular damage from extreme hyperthermia. Heat stroke can be classified as classic (non-exertional), affecting vulnerable populations like the elderly during passive heat exposure, or exertional, occurring in active individuals from combined environmental and metabolic heat load. Mortality rates can reach 10-80% without prompt cooling, underscoring its position as the endpoint of untreated heat-related progression. Other less common manifestations, such as , involve transient swelling in the extremities from fluid shifts and during initial heat exposure, typically resolving with elevation and . Rhabdomyolysis, a rare but serious complication, features muscle breakdown releasing into the bloodstream, often following exertional , and can lead to kidney injury if not addressed. These disorders highlight the importance of environmental awareness, as risk increases with factors like high humidity, which impairs evaporative cooling, and affects susceptible groups including children, the elderly, and those with chronic illnesses.

Drug-Induced Syndromes

Drug-induced hyperthermia encompasses a group of life-threatening syndromes characterized by uncontrolled elevation of core body temperature due to pharmacological agents that impair , often through disruption of control, excessive muscle activity, or interference with dissipation mechanisms. These conditions differ from environmental heat-related illnesses by their pharmacological triggers and distinct pathophysiological profiles, though they may share features like autonomic instability and . Recognition is critical, as mortality rates can exceed 10-20% without timely intervention, depending on the . One prominent example is malignant hyperthermia (MH), a pharmacogenetic disorder triggered primarily by volatile inhalational anesthetics (e.g., , ) and the depolarizing succinylcholine in genetically susceptible individuals. It arises from mutations in the RYR1 gene encoding the , leading to uncontrolled calcium release from the in , resulting in sustained muscle contraction, hypermetabolism, and rapid temperature rise often exceeding 40°C. Clinical presentation includes , , muscle rigidity, and , typically occurring intraoperatively or shortly after exposure. Diagnosis relies on clinical signs and, post-event, confirmatory caffeine- contracture testing on muscle biopsy. Treatment involves immediate discontinuation of triggering agents, administration of (a ) at 2.5 mg/kg IV initially, with repeat doses as needed, alongside supportive measures like cooling and fluid resuscitation; has dramatically reduced mortality from near 80% to under 5%. Neuroleptic malignant syndrome (NMS) is another severe reaction, most commonly associated with medications, particularly high-potency D2 receptor antagonists like or , though it can occur with abrupt withdrawal of agents in (parkinsonism-hyperpyrexia syndrome). The underlying mechanism involves central blockade in the and , leading to dysregulated , muscle rigidity, and sympathetic overactivity. Symptoms develop over hours to days and include severe hyperthermia (often >38.5°C), lead-pipe muscle rigidity, altered mental status, diaphoresis, and elevated levels indicative of . Diagnostic criteria, such as those from the , require exposure to a neuroleptic, exclusion of other causes, and at least two of rigidity, fever, autonomic changes, or elevated CK. entails immediate cessation of the offending drug, supportive care including aggressive cooling and hydration, and pharmacotherapy with or agonists like ; benzodiazepines may help control agitation, and mortality ranges from 5-10% with prompt treatment. Serotonin syndrome results from excessive serotonergic activity, typically from therapeutic doses or overdoses of agents like selective serotonin reuptake inhibitors (SSRIs, e.g., ), inhibitors (MAOIs), or combinations with other serotonergics such as or . Pathophysiologically, it involves overstimulation of 5-HT1A and 5-HT2A receptors, causing autonomic hyperactivity, neuromuscular excitation, and impaired heat dissipation, with hyperthermia arising from increased muscle activity and shivering. The triad of presentation includes altered mental status (agitation, confusion), autonomic dysfunction (, , hyperthermia >38°C), and neuromuscular abnormalities (, , ); severe cases may progress to seizures or . Diagnosis uses Hunter criteria, emphasizing serotonergic agent exposure and specific features like inducible . Treatment focuses on discontinuing precipitating drugs, providing supportive care (e.g., benzodiazepines for muscle rigidity, cooling for hyperthermia), and, in moderate-to-severe cases, administering (a serotonin ) at 12 mg initially followed by 2 mg every 2 hours; mortality is low (<1%) with early recognition but rises with delayed intervention. Additional syndromes include sympathomimetic toxicity from stimulants like cocaine, amphetamines, or MDMA, which enhance catecholamine release and metabolic rate, leading to agitation, seizures, and hyperthermia via excessive heat production from muscle hyperactivity and vasoconstriction that hinders dissipation. Clinical features encompass tachycardia, mydriasis, and temperatures up to 42°C, managed with sedation (e.g., benzodiazepines), cooling, and avoiding beta-blockers due to unopposed alpha stimulation. Similarly, anticholinergic toxicity from drugs like atropine, diphenhydramine, or tricyclic antidepressants blocks muscarinic receptors, inhibiting sweating and causing delirium, dry skin, urinary retention, and hyperthermia from uncompensated heat gain. Treatment involves supportive measures, activated charcoal if recent ingestion, and physostigmine in severe cases for reversal, with cooling essential to prevent progression to rhabdomyolysis. Across these syndromes, risk factors include polypharmacy, dehydration, and concurrent infections, emphasizing the need for vigilance in patients on implicated medications. Early detection through monitoring vital signs and laboratory markers like CK and electrolytes is paramount, as is multidisciplinary care in critical settings to mitigate complications such as acute kidney injury or disseminated intravascular coagulation.

Other Forms

Other forms of hyperthermia encompass conditions arising from central nervous system dysfunction or endocrine disorders, where the body's thermoregulatory mechanisms are disrupted without primary involvement of environmental heat exposure or pharmacological triggers. These forms are characterized by an inability to maintain euthermia due to direct impairment of the hypothalamus, brainstem, or hormonal pathways that influence heat production and dissipation. Unlike classic heat-related illnesses, which stem from external thermal stress, or drug-induced syndromes like malignant hyperthermia, these presentations often manifest in acute neurological or metabolic crises and require targeted diagnostic evaluation to distinguish them from infectious fevers. Central hyperthermia results from lesions or injuries affecting the hypothalamic-pituitary axis or brainstem thermoregulatory centers, leading to uncontrolled heat generation or impaired heat loss. Common causes include intracerebral hemorrhage, ischemic stroke, traumatic brain injury, subarachnoid hemorrhage, and tumors involving the brainstem or diencephalon. For instance, brainstem hemorrhage accounts for approximately 64% of central hyperthermia cases in acute stroke settings, often presenting with rapid-onset temperature elevations exceeding 39°C, marked fluctuations, and resistance to antipyretic therapy. In fatal cases of cerebral hemorrhage, particularly those involving the brainstem such as pontine hemorrhage, high body temperature is frequently observed at or near the time of death, resulting from damage to thermoregulatory centers (e.g., hypothalamus or brainstem) and linked to rapid deterioration, brain herniation, and high mortality risk, often within hours to days. These episodes arise because damage to inhibitory pathways in the preoptic area of the hypothalamus disrupts the normal feedback loop that balances heat production and dissipation, potentially exacerbating neuronal injury through secondary metabolic stress. Diagnosis typically involves neuroimaging to identify structural lesions, as routine blood cultures and antimicrobials fail to resolve the hyperthermia. Management may include dopamine agonists like bromocriptine to restore dopaminergic inhibition of thermogenesis, alongside supportive cooling measures, with studies showing temperature reductions of 1-2°C within hours of administration in responsive cases. Endocrine-related hyperthermia occurs when dysregulated hormone secretion overwhelms thermoregulatory capacity, often in the context of acute decompensation of underlying glandular disorders. Thyroid storm, a life-threatening manifestation of severe , is a prototypical example, triggered by stressors such as infection or surgery in patients with untreated or toxic nodular goiter, resulting in excessive thyroid hormone release that accelerates basal metabolic rate and heat production. Core temperatures can surpass 40°C, accompanied by tachycardia, agitation, and multiorgan failure, with mortality rates approaching 20-30% if untreated. Similarly, pheochromocytoma crisis involves episodic catecholamine surges from adrenal medullary tumors, inducing vasoconstriction and hypermetabolism that elevate body temperature to dangerous levels, often mimicking sympathomimetic toxicity. Thyroiditis, particularly subacute forms, may also provoke transient hyperthermia through inflammatory hormone leakage. Treatment prioritizes hormone-specific interventions, such as beta-blockers and antithyroid drugs for thyroid storm or alpha-blockade for pheochromocytoma, combined with aggressive cooling to mitigate complications like rhabdomyolysis. Early recognition via thyroid function tests or plasma metanephrines is critical, as these conditions respond poorly to nonspecific antipyretics.

Signs and Symptoms

Mild and Moderate Presentations

Mild presentations of hyperthermia encompass less severe heat-related disorders that typically arise from prolonged exposure to hot environments or physical exertion without adequate hydration and cooling. These conditions serve as early warnings and are generally reversible with prompt intervention. Common mild forms include heat rash, heat edema, heat syncope, and . Heat rash, also known as prickly heat or miliaria, manifests as small, red, itchy blisters or bumps on the skin, often in areas where sweat accumulates such as the neck, chest, groin, or elbow creases. It results from blocked sweat ducts due to heat and humidity, leading to inflammation and discomfort. Heat edema involves mild swelling in the extremities, particularly the ankles and feet, caused by vasodilation and fluid retention in response to heat exposure. Heat syncope presents as sudden dizziness, lightheadedness, or fainting, especially upon standing after prolonged sitting or lying down in hot conditions. This occurs due to dehydration-induced hypotension and peripheral blood pooling, reducing cerebral blood flow. Heat cramps are characterized by painful, involuntary muscle spasms, typically in the legs, arms, or abdomen, following intense exercise in warm weather. These cramps stem from electrolyte imbalances, particularly sodium and potassium loss through heavy sweating, despite a normal or only slightly elevated core body temperature. Moderate presentations, primarily heat exhaustion, represent a more advanced stage where the body's thermoregulatory mechanisms are overwhelmed but central nervous system function remains intact. Symptoms include heavy sweating, profound fatigue or weakness, dizziness, headache, nausea, vomiting, and muscle cramps. Affected individuals often exhibit cool, pale, or flushed moist skin, a rapid but weak pulse, low blood pressure upon exertion, and a core temperature typically between 101°F and 104°F (38.3°C to 40°C). Thirst, irritability, and decreased urine output may also occur due to dehydration. If untreated, moderate hyperthermia can progress to severe forms, but early recognition allows for effective management through rest, hydration, and cooling measures.

Severe and Life-Threatening Features

In severe hyperthermia, particularly heatstroke, the core body temperature often exceeds 40°C (104°F), marking a critical failure of thermoregulation that can rapidly progress to multi-organ dysfunction if untreated. This elevation disrupts cellular function and triggers a cascade of life-threatening symptoms, primarily affecting the central nervous system, where confusion, agitation, delirium, ataxia, slurred speech, seizures, and coma are hallmark signs of . These neurological manifestations arise from direct heat-induced neuronal damage and cerebral edema, often appearing abruptly after prolonged heat exposure or exertion, and they indicate a high risk of permanent brain injury or death without immediate intervention. Cardiovascular instability is another prominent feature, characterized by tachycardia (heart rate often >100 beats per minute), widened , and in approximately 25% of cases, reflecting , myocardial strain, and potential arrhythmias. Respiratory compromise manifests as and arterial (PaCO₂ <20 mmHg), which can evolve into acute respiratory distress syndrome (ARDS) due to pulmonary inflammation and capillary leakage. Skin findings vary by subtype: in classic heatstroke, hot, dry, anhidrotic skin predominates due to sweat gland failure, while exertional heatstroke may involve profuse sweating initially, followed by dehydration. These vital sign abnormalities, combined with altered mental status, underscore the medical emergency, with mortality rates exceeding 50% in untreated classic cases among vulnerable populations. In drug-induced hyperthermia syndromes like malignant hyperthermia, symptoms intensify with severe muscle rigidity, rhabdomyolysis, and metabolic derangements, including hypercapnia (elevated CO₂), acidosis, and mottled skin from vasomotor instability. Rapid heart rate and irregular rhythms accompany a core temperature rise up to 42°C or higher, often triggered by anesthetics, leading to disseminated intravascular coagulation (DIC), renal failure, and cardiac arrest if not reversed promptly with . Similarly, exertional hyperthermia in athletes or laborers presents with seizures, coma, and profound weakness, exacerbated by electrolyte imbalances and myoglobinuria, highlighting the syndrome's potential for irreversible organ damage even after cooling.

Causes and Risk Factors

Environmental and Situational Factors

Environmental factors play a critical role in precipitating by overwhelming the body's thermoregulatory capacity, particularly when ambient conditions hinder heat loss through radiation, convection, and evaporation. High temperatures, especially above 35°C (95°F), combined with elevated humidity levels that exceed 60%, significantly reduce the efficiency of sweat evaporation, the primary mechanism for cooling during heat stress. This interaction is quantified by the , a metric that integrates air temperature, humidity, wind speed, and solar radiation to assess heat strain risk; WBGT values above 28°C are associated with increased incidence of heat-related illnesses in exposed populations. has intensified these risks by increasing the frequency, duration, and intensity of heatwaves, leading to an estimated 489,000 heat-related deaths annually worldwide between 2000 and 2019, with disproportionate impacts in Asia and Europe; trends indicate continued rises in heat-related mortality as of 2023. Urban environments amplify environmental heat exposure through the urban heat island effect, where concrete, asphalt, and reduced vegetation trap heat, raising local temperatures by 2–5°C compared to rural areas, particularly at night when cooling is limited. Direct solar radiation without shade further exacerbates this, as ultraviolet exposure increases skin temperature and overall heat load, contributing to hyperthermia in outdoor settings like parks or construction sites. In regions affected by prolonged heat events, such as the that caused over 70,000 excess deaths, these factors interact to elevate vulnerability, especially during summer months when nighttime temperatures fail to drop below 20°C. Situational factors often compound environmental stressors, creating acute risks in specific contexts such as occupational settings or confined spaces. Prolonged work in hot environments, such as agriculture, construction, or without adequate breaks or hydration, leads to exertional hyperthermia; data indicate thousands of occupational heat-related illnesses and injuries annually in the United States, with dehydration and lack of acclimatization—typically requiring 7–14 days of gradual exposure—heightening susceptibility. Enclosed vehicles represent a particularly lethal situational hazard, especially for young children, whose higher metabolic rates and immature thermoregulation cause rapid core temperature rises; the notes that pediatric vehicular hyperthermia accounts for about 37 child deaths per year in the U.S., often when vehicles heat to over 49°C (120°F) within 30 minutes on sunny days. Additional situational contributors include power outages during heat events, which disable air conditioning and increase indoor temperatures, and homelessness, where lack of shelter exposes individuals to unrelenting ambient heat. Bulky or non-breathable clothing, common in certain professions or cultural practices, traps heat and moisture, while absence of access to cooling resources like shade or water in remote or low-income areas further elevates risk, as seen in informal urban settlements where heat-amplifying materials like metal roofs intensify exposure.

Exertional and Physiological Contributors

Exertional hyperthermia occurs when intense physical activity in warm or hot environments leads to excessive endogenous heat production that surpasses the body's capacity for heat dissipation. During strenuous exercise, skeletal muscles generate significant metabolic heat, which, combined with environmental heat load, elevates core body temperature. This process is exacerbated by prolonged duration or high intensity of activity, such as in endurance sports or military training, where metabolic rates can increase heat production by 10- to 20-fold above resting levels. Factors like inadequate recovery periods between exertional bouts further impair heat loss, promoting a rapid rise in core temperature that can reach dangerous levels within minutes to hours. Physiological contributors play a critical role in susceptibility to exertional hyperthermia by influencing thermoregulatory efficiency. Lack of heat acclimatization, which typically develops over 7-14 days of repeated exposure to heat, diminishes sweating capacity and cardiovascular stability, making unacclimatized individuals more prone to overheating during exercise. Dehydration, often resulting from insufficient fluid intake relative to sweat losses, reduces plasma volume and skin blood flow, thereby limiting evaporative cooling; even mild dehydration (2% body mass loss) can significantly impair thermoregulatory capacity. Poor aerobic fitness levels correlate with higher core temperatures during exercise, as less fit individuals exhibit reduced cardiovascular efficiency and greater reliance on anaerobic metabolism, which produces additional heat. Individual physiological variations further modulate risk. Older age is associated with diminished thermoregulatory responses, including reduced sweat gland output and slower vascular adjustments, increasing vulnerability in elderly athletes or workers. Sex differences show that females may experience higher heat strain due to lower sweat rates and higher body fat percentages, though estrogen's protective effects on cardiovascular function can mitigate this in some cases. Body composition influences heat storage, with higher adiposity leading to greater insulation and reduced surface area-to-mass ratio for heat loss; for instance, individuals with elevated body mass index often display 0.5-1°C higher core temperatures during equivalent exercise workloads. Previous heat-related illness heightens recurrence risk by potentially causing lasting impairments in sweat gland function or endothelial health. Electrolyte imbalances, such as hyponatremia from overhydration or hypokalemia from sweat loss, can disrupt neuromuscular function and exacerbate hyperthermic stress.

Pharmacological and Medical Triggers

Hyperthermia can arise from various pharmacological agents that disrupt thermoregulatory mechanisms in the hypothalamus or peripheral systems, often leading to life-threatening syndromes. Common triggers include anesthetic gases and depolarizing muscle relaxants, which provoke malignant hyperthermia (MH) in genetically susceptible individuals by causing uncontrolled calcium release in skeletal muscle, resulting in hypermetabolism and rapid temperature elevation. Antipsychotics, particularly typical agents like haloperidol, can induce neuroleptic malignant syndrome (NMS) through dopamine D2 receptor blockade, leading to muscle rigidity, autonomic instability, and core temperatures exceeding 40°C. Sympathomimetic drugs such as cocaine, amphetamines, and elevate body temperature by stimulating central and peripheral adrenergic activity, increasing metabolic heat production and impairing heat dissipation via vasoconstriction. Serotonergic agents, including selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs), particularly when combined, trigger serotonin syndrome characterized by hyperthermia due to excessive serotonergic stimulation in the central nervous system. Anticholinergic medications, like atropine or tricyclic antidepressants, contribute to hyperthermia by inhibiting sweat gland function and causing central delirium, reducing evaporative cooling. Beyond direct drug effects, certain medical conditions predispose individuals to hyperthermia by overwhelming thermoregulatory capacity or generating excessive internal heat. Severe infections, such as sepsis from bacterial sources like Staphylococcus aureus, can cause hyperthermia through cytokine-mediated hypothalamic resetting, though this blurs into fever patterns; in extreme cases, it progresses to uncontrolled hyperpyrexia. Endocrine disorders, including thyroid storm—a hypermetabolic crisis in thyrotoxicosis—elevate temperature via increased basal metabolic rate and sympathetic overdrive, often reaching 41°C or higher. Neurological insults represent another key category, where conditions like status epilepticus or acute stroke impair hypothalamic function, leading to central hyperthermia without infection. Pheochromocytoma, a catecholamine-secreting tumor, induces episodic hyperthermia through massive adrenergic surges, mimicking sympathomimetic toxicity. Additionally, tetanus toxin blocks inhibitory neurotransmitters, causing sustained muscle contractions and heat-generating rigidity. These triggers often interact with environmental factors, amplifying risk in vulnerable populations such as the elderly or those with cardiovascular disease.

Pathophysiology

Thermoregulatory Mechanisms

Thermoregulation in humans involves a complex interplay of physiological processes that maintain core body temperature near 37°C by balancing heat production with heat dissipation. The serves as the primary thermoregulatory center, integrating inputs from peripheral and central temperature sensors to orchestrate responses via the autonomic nervous system. Peripheral thermoreceptors in the skin detect environmental temperature changes, while central sensors in the hypothalamus and spinal cord monitor core temperature variations. When core temperature rises, the hypothalamus triggers heat-loss mechanisms, including cutaneous vasodilation, which increases skin blood flow to facilitate convective and radiative heat transfer to the environment, and sweating, which enables evaporative cooling through water vaporization from the skin surface. These processes can dissipate up to 1-2 kW of heat under optimal conditions, primarily via evaporation accounting for over 80% of heat loss during heat stress. In the context of hyperthermia, these mechanisms become insufficient when heat gain from metabolism, exercise, or the environment exceeds dissipation capacity. For instance, high ambient temperatures or humidity impair evaporative cooling, while conditions like dehydration reduce sweat production, leading to unchecked rises in core temperature. Pharmacological agents, such as sympathomimetics, can further disrupt regulation by increasing metabolic heat production or inhibiting vasodilation and sweating. Behavioral adaptations, such as seeking shade or reducing activity, complement physiological responses under hypothalamic control, but in severe hyperthermia, failure of these integrated systems results in systemic damage as core temperature surpasses 40°C.

Cellular and Systemic Damage

Hyperthermia induces cellular damage primarily through direct thermal effects on biomolecules and cellular structures. At core temperatures exceeding 40°C, proteins begin to denature, leading to loss of enzymatic function and structural integrity, which disrupts essential cellular processes such as metabolism and signaling. In response to this stress, cells activate the heat shock response, inducing heat shock proteins (HSPs), particularly HSP70, which act as molecular chaperones to refold denatured proteins, inhibit apoptosis, and provide cytoprotection. However, at higher temperatures or prolonged exposure, this protective mechanism can be overwhelmed. Mitochondrial dysfunction follows, impairing ATP production and increasing reactive oxygen species (ROS), which further exacerbate oxidative stress and lipid peroxidation in cell membranes. Membrane stability is compromised, resulting in altered ion transport, including elevated intracellular sodium and calcium levels alongside reduced potassium efflux, which can trigger excitotoxicity in neurons via excessive glutamate release. Cell death pathways are activated around 40–41°C, with apoptosis predominating in early stages due to cytochrome c release from damaged mitochondria, progressing to necrosis at higher temperatures or prolonged exposure, particularly in thermosensitive cells like those undergoing mitosis. Systemically, hyperthermia triggers a cascade of inflammatory and coagulopathic responses that amplify organ dysfunction. Increased gastrointestinal permeability, observed above 40°C, allows bacterial translocation and endotoxin release into the bloodstream, initiating a systemic inflammatory response syndrome (SIRS) characterized by elevated pro-inflammatory cytokines such as IL-6 and TNF-α. This "cytokine storm" contributes to endothelial activation and damage, promoting microvascular thrombosis and ischemia in multiple organs. In the central nervous system, blood-brain barrier permeability rises at temperatures over 38–39°C, facilitating cerebral edema and neuronal injury, compounded by initial increases in cerebral blood flow that may reverse to hypoperfusion above 40°C, worsening hypoxia. Multiorgan failure ensues, affecting the liver (via hepatocellular necrosis), kidneys (acute tubular injury from hypoperfusion and direct toxicity), cardiovascular system (arrhythmias and myocardial depression), and coagulation (disseminated intravascular coagulation), with mortality rates reaching up to 64% when core temperatures surpass 40°C. These systemic effects underscore hyperthermia's progression from localized thermal stress to widespread pathophysiological derangement.

Diagnosis

Clinical Evaluation

Hyperthermia diagnosis varies by type, with environmental and exertional forms (often manifesting as heat stroke) relying on clinical assessment, while drug-induced syndromes and malignant hyperthermia involve specific triggers and confirmatory tests (detailed in the Classification and Types section). For heat-related hyperthermia, the clinical evaluation begins with a rapid assessment to confirm the diagnosis, which is primarily based on the classic triad of elevated core body temperature exceeding 40°C (104°F), central nervous system (CNS) dysfunction, and a history of exposure to high environmental heat or strenuous physical activity. This approach allows for prompt recognition in emergency settings, where delays can lead to irreversible organ damage. Clinicians must differentiate hyperthermia from fever by noting the absence of an infectious or inflammatory trigger, as hyperthermia results from failed thermoregulation rather than a hypothalamic set-point elevation. For malignant hyperthermia, a rare genetic disorder, diagnosis is suspected intraoperatively upon exposure to triggering anesthetics (e.g., volatile agents or succinylcholine), presenting with rapid rises in end-tidal CO2, tachycardia, muscle rigidity, and hyperthermia; confirmation occurs post-event via caffeine-halothane contracture testing on muscle biopsy or genetic analysis of RYR1 mutations. Drug-induced hyperthermia, such as neuroleptic malignant syndrome (from antipsychotics) or serotonin syndrome (from SSRIs/MAOIs), is identified through medication history, autonomic instability, rigidity or hyperreflexia, and elevated creatine kinase, often using diagnostic scales like the Naranjo algorithm for causality. A thorough history is essential to identify risk factors and contextualize the presentation for heat-related cases. Key elements include the duration and intensity of heat exposure, level of physical exertion, clothing and hydration status, use of medications (e.g., anticholinergics, diuretics, or stimulants that impair sweating or increase metabolic heat production), and underlying conditions such as cardiovascular disease, obesity, or dehydration. Prodromal symptoms like fatigue, dizziness, nausea, or muscle cramps—indicative of progression from heat exhaustion—should be elicited, along with any witnesses' accounts of the patient's behavior leading to collapse. In exertional hyperthermia, common among athletes or laborers, the history often reveals intense activity in hot, humid conditions without adequate acclimatization. The physical examination focuses on confirming hyperthermia and assessing its severity through vital signs and systemic evaluation. Core body temperature should be measured rectally, esophageally, or via bladder catheter, as axillary or oral methods underestimate readings above 40°C; a temperature of 40.5°C or higher supports the diagnosis. Patients typically exhibit tachycardia (heart rate >100 bpm), , and due to and . Skin findings vary: hot and dry anhidrotic skin in classic (non-exertional) hyperthermia versus hot and diaphoretic in exertional cases. Neurological assessment is critical, revealing altered mental status ranging from and agitation to seizures, , or decerebrate posturing, which distinguish severe hyperthermia from milder heat illnesses. Additional findings may include muscle rigidity, , or signs of such as dry mucous membranes and reduced turgor. Frequent serial monitoring of and mental status is recommended during to track progression, with immediate intervention warranted if deterioration occurs. The also involves excluding mimics like , , or through contextual clues, though confirmatory tests are deferred to subsequent diagnostic steps. This structured clinical approach ensures accurate identification and guides urgent .

Laboratory and Imaging Confirmation

Laboratory confirmation of hyperthermia, particularly in cases of heat stroke, involves assessing core body temperature and evaluating for systemic organ dysfunction, electrolyte imbalances, and metabolic derangements through targeted blood tests. Core temperature measurement, typically via rectal or esophageal probe, is essential to confirm hyperthermia with readings exceeding 40°C (104°F), distinguishing it from fever. Serum electrolytes are routinely checked to identify abnormalities such as hyponatremia due to excessive sweating or hypernatremia from dehydration, while hypokalemia may result from gastrointestinal losses or renal compensation. A complete blood count (CBC) often reveals leukocytosis indicative of stress response, and a basic metabolic panel assesses renal function with elevated blood urea nitrogen (BUN) and creatinine signaling acute kidney injury from hypoperfusion or rhabdomyolysis. Liver function tests (LFTs) demonstrate transaminitis, with aspartate aminotransferase (AST) and (ALT) levels rising rapidly due to hepatic ischemia, often peaking within hours and correlating with disease severity. (CK) levels are markedly elevated in exertional hyperthermia, reflecting muscle breakdown and , which can exceed 10,000 U/L and contribute to renal complications. studies, including (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR), are critical to detect disseminated intravascular coagulation (DIC), a common complication with prolonged times and . Arterial blood gas (ABG) analysis typically shows with elevated lactate levels from tissue hypoperfusion and anaerobic metabolism, while may indicate or in cases. Additional screens for glucose, function, and help rule out contributing factors like , , or drug-induced hyperthermia. For non-heat-related forms, labs may include for MH (RYR1 sequencing) or elevated CK and in drug-induced cases to support . studies play a supportive role in confirming hyperthermia-related complications rather than serving as primary diagnostic tools, given the condition's clinical basis. Chest is recommended initially to evaluate for (ARDS) or , which can manifest as bilateral infiltrates in severe cases. Computed tomography (CT) of the head is indicated if focal neurological deficits persist after cooling, to exclude , , or other mimics, though findings in hyperthermia itself are often normal acutely. In the subacute or late phase, (MRI) reveals characteristic bilateral symmetric lesions, including ischemia and malacia in the , , and , reflecting direct thermal injury and hypoxic damage; diffusion-weighted highlights restricted diffusion in affected areas. These features, while not diagnostic in isolation, in prognostic assessment and differentiation from infectious or vascular etiologies.

Treatment

Initial Stabilization

Initial stabilization in hyperthermia treatment focuses on rapidly addressing life-threatening instability while initiating core temperature reduction to mitigate organ damage. The primary priorities are securing the patient's airway, breathing, and circulation (ABCs), followed by immediate removal from the heat source and supportive measures to restore hemodynamic stability. Upon arrival, the patient is assessed for , including core body temperature via rectal , as this provides the most accurate reading for guiding interventions. Clothing is removed to expose the skin, and the individual is placed in a cool, shaded environment to halt further heat gain. Oxygen is administered if hypoxia is present, and intravenous access is established for fluid resuscitation with isotonic crystalloids (e.g., normal saline or lactated Ringer's) at 20 mL/kg boluses to correct and support , while monitoring for fluid overload. Aggressive cooling is commenced simultaneously with stabilization, targeting a reduction in core temperature to below 39°C as quickly as possible. For exertional hyperthermia, cold water immersion (up to level at 1–15°C) is the preferred method in prehospital settings, achieving cooling rates of 0.15–0.35°C per minute. If immersion is unavailable, evaporative cooling—combining water misting and air flow from fans—or application of ice packs to high-heat-loss areas (, axillae, , and ) can be used, with rates of 0.1–0.2°C per minute. Cooling efforts continue en route to definitive care, but are adjusted to avoid overshoot once the target temperature is reached. Neurological status is continuously monitored, with intubation considered for altered mental status or to protect the airway. Seizures, if present, are managed with benzodiazepines, and cardiac arrhythmias are treated per protocols. In suspected triggered by anesthetics, initial steps also include hyperventilation with 100% oxygen and discontinuation of volatile agents, though specific antidotal therapy follows stabilization.

Targeted Interventions

Targeted interventions for hyperthermia focus on rapidly reversing the core temperature elevation and addressing underlying pathophysiological mechanisms, tailored to the type of hyperthermia—whether exertional, environmental, or pharmacologically induced. For exertional heatstroke and classic heatstroke, the primary intervention is aggressive conductive cooling, with evidence strongly supporting cold-water immersion as the most effective method to achieve a cooling rate of 0.15–0.20°C per minute, reducing mortality from over 50% to less than 5% when initiated within 30 minutes of collapse. Ice-water immersion involves submerging the patient up to the neck in water at 1–2°C, which facilitates through conduction and has been validated in large case series as superior to other methods like evaporative cooling or ice packs. In settings where immersion is impractical, such as prehospital environments, tarp-assisted cooling with ice-water (TACO) provides a viable alternative, achieving comparable cooling rates to immersion while being field-deployable. For pharmacologically triggered hyperthermia, such as (MH) induced by volatile anesthetics or succinylcholine, sodium is the cornerstone , acting as a by inhibiting calcium release from the to halt the hypermetabolic crisis. The Association of the recommends an initial intravenous bolus of 2.5 mg/kg, repeated up to 10 mg/kg total, followed by maintenance infusions, which has demonstrated efficacy in multicenter studies by rapidly normalizing temperature and preventing complications like . Supportive targeted measures include discontinuing triggering agents and hyperventilating with 100% oxygen, alongside monitoring for compartmental to optimize dosing in adults. In (NMS), a related condition, may be used adjunctively at 1–2 mg/kg doses, though evidence is less robust compared to MH, with supportive care emphasizing dopamine agonists like for symptom control. Additional targeted interventions address complications such as or , including intravenous fluid with balanced crystalloids to maintain without overhydration, and judicious use of benzodiazepines for agitation without impairing . In severe cases, extracorporeal cooling devices like venovenous can be employed for patients with multiorgan failure, providing both and renal support, though these are reserved for refractory hyperthermia due to their invasiveness. Overall, these interventions prioritize rapidity and specificity, with outcomes improving significantly when core temperature is reduced below 40°C promptly.

Prevention

Individual Strategies

Individual strategies for preventing hyperthermia focus on personal behaviors and habits that mitigate heat exposure, promote , and address individual risk factors, such as age, conditions, or medications that impair sweating or increase risk. These approaches are essential because hyperthermia arises from the body's inability to dissipate heat effectively, often exacerbated by environmental conditions and physical exertion. By adopting proactive measures, individuals can significantly reduce the incidence of heat-related illnesses, including and heatstroke. Hydration is a of prevention, as adequate fluid intake maintains and supports sweating, the primary cooling mechanism. Individuals should drink plenty of or electrolyte-containing beverages throughout the day, even before feeling thirsty, aiming for clear or light-colored as an indicator of sufficient hydration. Avoiding alcohol, , and sugary drinks is advised, as they can promote . For those on diuretics or other medications affecting , consulting a healthcare provider for adjusted intake is recommended. Studies emphasize that consistent hydration helps prevent increases in core body temperature during heat exposure by countering effects. Clothing and sun protection play a critical role in reducing radiant heat absorption and allowing skin evaporation. Lightweight, loose-fitting, light-colored clothing facilitates airflow and reflects sunlight, while wide-brimmed hats and sunscreen (SPF 30 or higher) prevent sunburn, which impairs heat dissipation. Scheduling outdoor activities for cooler times—early morning or evening—and taking frequent breaks in shaded or air-conditioned areas further minimizes risk. Gradual acclimatization over 7-14 days, by increasing exposure to heat slowly, enhances physiological adaptations like improved sweat efficiency. Personal monitoring and environmental awareness are vital for early intervention. Individuals, especially older adults or those with chronic conditions, should track weather alerts, recognize early symptoms like or excessive sweating, and seek cool environments promptly—such as air-conditioned spaces or cool baths. Never leaving vulnerable individuals, like children or pets, in vehicles is a non-negotiable rule, as interior temperatures can rise rapidly to lethal levels. These strategies, when combined, can significantly reduce heat-related emergency visits in at-risk populations.

Community and Occupational Measures

Community measures to prevent hyperthermia focus on coordinated responses through heat action plans, which integrate early warning systems, risk mapping, and targeted interventions to protect vulnerable populations such as the elderly, children, and those with chronic conditions. These plans, often developed in collaboration with meteorological services, involve issuing heat alerts via media and apps when temperatures exceed thresholds, enabling timely activation of resources like cooling centers in public buildings, libraries, and community halls to provide air-conditioned relief during heatwaves. Public education campaigns emphasize hydration, avoiding strenuous activity during peak heat, and recognizing symptoms, with community outreach targeting low-income neighborhoods lacking home cooling. Multi-sectoral efforts enhance these initiatives by addressing urban heat islands through green infrastructure, such as planting trees and creating reflective surfaces in cities, which can reduce local temperatures by 2–4°C and lower hyperthermia risks in densely populated areas. systems play a key role by training emergency responders and increasing hospital capacity during alerts, while social services ensure transportation to cooling sites for at-risk groups; for example, integrated heat action plans in the WHO European Region have demonstrated reductions in heat-related hospitalizations. Occupational measures prioritize workplace heat stress prevention, guided by criteria from the National Institute for Occupational Safety and Health (NIOSH) and proposed OSHA standards, which recommend employers to assess heat hazards using the and implement controls when it reaches 80°F (27°C) (as of 2025). As of November 2025, OSHA's federal heat standard remains proposed, with finalization anticipated in 2026, while some states enforce similar requirements. Core strategies include providing ample cool water (at least one per hour per worker), mandatory rest breaks in shaded or cooled areas every 15–20 minutes in high-risk conditions, and programs allowing new workers 1–2 weeks to adjust gradually to hot environments. , such as fans, ventilation, and scheduling heavy work for cooler times, are preferred over administrative measures, with like cooling vests used when necessary for roles in , , and . Employers must train workers on hyperthermia symptoms and , conduct medical surveillance for those with pre-existing conditions, and maintain emergency plans including on-site cooling methods like ice packs or immersion tubs. The American College of Occupational and Environmental Medicine (ACOEM) endorses a hierarchy of controls, emphasizing that comprehensive programs can reduce occupational incidence by up to 50% in high-exposure industries.

Epidemiology

Incidence and Distribution

Hyperthermia, encompassing severe heat-related illnesses such as heatstroke, contributes significantly to global morbidity and mortality, with incidence influenced by , , and socioeconomic factors. Between 2000 and 2019, heat-related deaths averaged approximately 489,000 annually worldwide, representing a key indicator of the condition's burden. These deaths disproportionately affect vulnerable populations, with projections indicating a rise in heat-attributable mortality by up to 68% for individuals over 65 in recent decades due to intensifying events. Geographically, bears the highest burden, accounting for 45% of global heat-related deaths during the 2000–2019 period, followed by at 36%, while and other regions face underreported but rapidly growing risks amid limited . In subtropical areas, such as parts of , incidence rates of heat-related illnesses have shown marked regional variation, with higher concentrations in central and northern counties like and , linked to agricultural and industrial exposures; nationally, rates increased from 1.76 per 10,000 population in 2000 to 4.17 per 10,000 in 2018. In the United States, emergency department visits for heat-related illnesses peak in the Northeast, upper Midwest, and Mountain regions, reflecting vulnerabilities in cooler climates during extreme heat waves. Incidence data reveal an upward trend globally, driven by , correlating with rising temperatures and frequency. Urban heat islands exacerbate distribution patterns, concentrating cases in densely populated cities across low- and middle-income countries, where access to cooling and healthcare remains uneven. Overall, while comprehensive global incidence figures are limited by surveillance gaps, available evidence underscores hyperthermia's uneven distribution, with the greatest impacts in tropical and subtropical zones. As of 2025, heat-related deaths have increased to an average of 546,000 annually, a 23% rise since the . Certain populations face heightened risks of hyperthermia due to physiological, environmental, and socioeconomic factors. Older adults aged 65 and above are particularly vulnerable because of diminished thermoregulatory capacity, reduced thirst sensation, and higher prevalence of chronic conditions such as , , and respiratory disorders. Children, especially infants, are also at elevated risk owing to their higher metabolic rates and limited ability to dissipate heat effectively. Individuals with preexisting health conditions, including disorders, , and , experience exacerbated risks, as heat stress can worsen these conditions and impair adaptive responses. Outdoor laborers, athletes, and homeless individuals represent occupational and socioeconomic risk groups, as prolonged exposure to high temperatures without adequate hydration or cooling measures increases susceptibility to exertional hyperthermia. Pregnant women and those in urban heat islands—disproportionately affecting low-income and communities of color—face compounded dangers, with studies indicating higher heat-related mortality rates among and populations compared to White populations . Males account for approximately 70% of heat-related deaths, potentially linked to higher rates of outdoor work and risk-taking behaviors. Epidemiological trends show a rising global burden of hyperthermia linked to , with heat-related mortality among people over 65 increasing by about 85% between 2000–2004 and 2017–2021. From 2000 to 2019, an estimated 489,000 heat-attributable deaths occurred annually worldwide, predominantly in and , underscoring the growing impact of more frequent and intense heatwaves. In the United States, heat-related visits peak in and , with rates averaging 303 per 100,000 visits in 2023. While some U.S. regions have seen stabilizing or decreasing vulnerability through adaptation measures like improved access, overall projections indicate continued increases in heat exposure for older adults through 2100 due to population aging and warming trends.

Research Directions

Recent Developments

In recent years, research on heat-related hyperthermia has increasingly emphasized the integration of evidence-based guidelines to improve clinical outcomes amid rising global temperatures. The Society of Critical Care Medicine (SCCM) released updated guidelines in February 2025 for the management of , recommending methods—such as cold-water immersion or evaporative cooling—over passive techniques like ice packs or fanning alone, based on a strong recommendation despite very low certainty of evidence from observational studies. These guidelines highlight the protocol's implementation in emergency departments, where immediate core temperature assessment followed by immersion in ice water for patients with temperatures above 40°C and altered mental status has shown feasibility and rapid cooling efficacy in small-scale implementations. Epidemiological research has documented escalating trends in hyperthermia incidence, underscoring the need for enhanced and prevention strategies. A 2024 analysis of U.S. heat-related deaths from 1999 to 2023 revealed a significant association between extreme heat exposure and mortality, with disproportionate impacts on older adults, males, and certain racial/ethnic groups, projecting further increases due to . In military populations, a 2025 report noted a 16.5% rise in incidence in 2024, reversing prior declines and attributing it to intensified training amid warmer conditions, prompting calls for real-time tools. A scoping review published in August 2025 synthesized global and regional efforts, identifying novel interventions like community-based cooling centers and heat vulnerability mapping as effective mitigation strategies, though gaps persist in low-resource settings and long-term outcome data. Emerging preclinical studies are exploring adjunctive therapies to address hyperthermia's multi-organ damage beyond cooling. A 2024 Lancet study investigated how common medications, including those listed by the for heat sensitivity (e.g., anticholinergics and diuretics), elevate core temperature responses during heat stress, informing personalized risk assessments in vulnerable patients. Furthermore, a 2025 Frontiers in Cell and article reported that mesenchymal stem cell-derived exosomes reduce and organ injury in animal models, suggesting potential for regenerative approaches, though human trials are needed to validate efficacy and safety. These developments collectively signal a shift toward multidisciplinary research integrating , technology, and to combat hyperthermia's growing burden.

Emerging Challenges

One of the primary emerging challenges in hyperthermia management is the escalating impact of , which is intensifying the frequency, duration, and severity of globally, thereby increasing the incidence of heat-related illnesses and associated mortality. Heat stress has become the leading cause of weather-related deaths, surpassing other natural disasters, and is projected to exacerbate underlying conditions such as , , respiratory disorders, and issues like anxiety and depression. In the United States, heat-related deaths rose from an average of 627 annually between 1999 and 2009 to 1,305 between 2016 and 2023, with disproportionate effects on older adults, children, and racial/ethnic minorities, highlighting the need for adaptive strategies. Vulnerable populations present another critical challenge, as urban heat islands, socioeconomic disparities, and occupational exposures amplify risks for outdoor workers, low-income communities, and those in resource-limited settings. For instance, children are experiencing a surge in emergency visits for heat-related illnesses, with nearly 20% requiring hospitalization during in 2025, underscoring gaps in pediatric prevention and rapid response protocols. In low-resource environments, limited access to cooling facilities, hydration, and timely medical intervention complicates treatment, particularly for severe cases like , where core temperatures exceed 40°C and dysfunction occurs. Research indicates that without integrated climate adaptation measures, these disparities could lead to a doubling of heat-related mortality in Latin American cities by 2050. Health systems worldwide face mounting pressures to enhance , including the development of early warning systems, pre-hospital cooling techniques, and equitable access to interventions, amid rising healthcare utilization for emergencies. A scoping review of strategies reveals that while some regions have implemented heat action plans, challenges persist in scaling them to address compound risks, such as combined with or pandemics, and in evaluating long-term effectiveness. Furthermore, the burden from prolonged exposure, including increased and suicides, demands interdisciplinary to integrate psychological support into hyperthermia response frameworks. Addressing these issues requires prioritizing high-impact, evidence-based policies that bridge gaps in predictive modeling and vulnerable group .

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK459311/
  2. https://www.chestnet.org/guidelines-and-topic-collections/topic-collections/articles/hyperthermia-heat-injury-and-heatstroke
  3. https://emcrit.org/ibcc/hyperthermia/
  4. https://my.clevelandclinic.org/health/diseases/22111-hyperthermia
  5. https://medlineplus.gov/ency/article/001315.htm
  6. https://www.mayoclinic.org/diseases-conditions/heat-stroke/symptoms-causes/syc-20353581
  7. https://www.cancer.gov/about-cancer/treatment/types/hyperthermia
  8. https://www.cancer.org/cancer/managing-cancer/treatment-types/hyperthermia.html
  9. https://www.ncbi.nlm.nih.gov/books/NBK553117/
  10. https://www.cdc.gov/niosh/heat-stress/about/illnesses.html
  11. https://www.emra.org/emresident/article/heat-related-illness
  12. https://pubmed.ncbi.nlm.nih.gov/9330841/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC9403255/
  14. https://pubmed.ncbi.nlm.nih.gov/23261898/
  15. https://pmc.ncbi.nlm.nih.gov/articles/PMC7851465/
  16. https://pubmed.ncbi.nlm.nih.gov/33508784/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC5606458/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC6370613/
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC5350322/
  20. https://pubmed.ncbi.nlm.nih.gov/19521083/
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC4926227/
  22. https://pubmed.ncbi.nlm.nih.gov/8303768/
  23. https://pubmed.ncbi.nlm.nih.gov/24176474/
  24. https://pubmed.ncbi.nlm.nih.gov/218448/
  25. https://www.aafp.org/pubs/afp/issues/2019/0415/p482.html
  26. https://www.hopkinsmedicine.org/health/conditions-and-diseases/heatrelated-illnesses-heat-cramps-heat-exhaustion-heat-stroke
  27. https://www.mayoclinic.org/first-aid/first-aid-heat-exhaustion/basics/art-20056651
  28. https://www.ncbi.nlm.nih.gov/books/NBK537135/
  29. https://www.mayoclinic.org/diseases-conditions/malignant-hyperthermia/symptoms-causes/syc-20353750
  30. https://www.who.int/news-room/fact-sheets/detail/climate-change-heat-and-health
  31. https://jamanetwork.com/journals/jama/fullarticle/2822854
  32. https://www.nejm.org/doi/full/10.1056/NEJMcp2210623
  33. https://www.cdc.gov/niosh/docs/2016-106/pdfs/2016-106.pdf
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC9466955/
  35. https://www.nhtsa.gov/sites/nhtsa.gov/files/812187_unattendedchildremindersystems.pdf
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC9978764/
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC2838466/
  38. https://pubmed.ncbi.nlm.nih.gov/36936589/
  39. https://physoc.onlinelibrary.wiley.com/doi/10.1113/EP088458
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC6783627/
  41. https://www.ncbi.nlm.nih.gov/books/NBK507838/
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC8227286/
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC9394784/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC2246210/
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC5008714/
  46. https://pubmed.ncbi.nlm.nih.gov/26794588/
  47. https://pubmed.ncbi.nlm.nih.gov/17645931/
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC4944485/
  49. https://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1376-4
  50. https://www.nejm.org/doi/full/10.1056/NEJMra1810762
  51. https://www.ncbi.nlm.nih.gov/books/NBK430828/
  52. https://bestpractice.bmj.com/topics/en-us/1053
  53. https://bestpractice.bmj.com/topics/en-us/849
  54. https://www.aafp.org/pubs/afp/issues/2005/0601/p2133.html
  55. https://emedicine.medscape.com/article/166320-clinical
  56. https://www.uptodate.com/contents/nonexertional-classic-heat-stroke-in-adults
  57. https://physoc.onlinelibrary.wiley.com/doi/10.1113/EP090488
  58. https://www.mayoclinic.org/diseases-conditions/heat-stroke/diagnosis-treatment/drc-20353587
  59. https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-019-0229-2
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC4704265/
  61. https://journals.lww.com/neur/fulltext/2017/65050/magnetic_resonance_imaging_findings_in_heat.48.aspx
  62. https://ttuhscep.edu/cme/_documents/Hyperthermia.pdf
  63. https://naemsp.org/2022-7-13-article-bites-41-consensus-statement-prehospital-care-of-exertional-heat-stroke/
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC6956553/
  65. https://www.saem.org/about-saem/academies-interest-groups-affiliates2/cdem/for-students/online-education/m4-curriculum/group-m4-environmental/hyperthermia
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC4027921/
  67. https://www.mhaus.org/healthcare-professionals/managing-a-crisis/
  68. https://www.cbp.gov/employee-resources/health-wellness/healthiercbp/heat-awareness/rapid-cooling-for-heat-stroke
  69. https://pubmed.ncbi.nlm.nih.gov/26525947/
  70. https://news.uark.edu/articles/37902/researchers-method-using-tarp-to-cool-person-with-heat-stroke-is-effective
  71. https://publichealth.buffalo.edu/exercise-and-nutrition-sciences/research-and-facilities/past-funded-research/tarp-assisted-cooling.html
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC12171246/
  73. https://pubmed.ncbi.nlm.nih.gov/7039419/
  74. https://poisoncontrol.utah.edu/news/2025/05/utility-of-dantrolene-treating-neuroleptic-malignant-syndrome-0
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC7972371/
  76. https://libres.uncg.edu/ir/uncg/f/W_Adams_Alternative_2019.pdf
  77. https://www.cdc.gov/climate-health/php/resources/protect-yourself-from-the-dangers-of-extreme-heat.html
  78. https://www.mayoclinic.org/diseases-conditions/heat-exhaustion/symptoms-causes/syc-20373250
  79. https://www.cdc.gov/heat-health/about/index.html
  80. https://pmc.ncbi.nlm.nih.gov/articles/PMC4131963/
  81. https://journals.physiology.org/doi/full/10.1152/physrev.00038.2020
  82. https://www.cdc.gov/extreme-heat/prevention/index.html
  83. https://www.cdc.gov/heat-health/risk-factors/heat-and-older-adults-aged-65.html
  84. https://newsnetwork.mayoclinic.org/discussion/safety-tips-to-prevent-heat-related-illness/
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC2793324/
  86. https://stacks.cdc.gov/view/cdc/93705
  87. https://ap-plat.nies.go.jp/inas/goodpractices/tool/8.html
  88. https://www.sciencedirect.com/science/article/abs/pii/S0013935122010362
  89. https://www.osha.gov/heat-exposure/standards
  90. https://www.cdc.gov/niosh/docs/2016-106/
  91. https://www.federalregister.gov/documents/2024/08/30/2024-14824/heat-injury-and-illness-prevention-in-outdoor-and-indoor-work-settings
  92. https://www.osha.gov/heat-exposure
  93. https://acoem.org/acoem/media/News-Library/Prevention_of_Occupational_Heat_Related_Illnesses-25.pdf
  94. https://pmc.ncbi.nlm.nih.gov/articles/PMC10289510/
  95. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-025-24344-1
  96. https://pmc.ncbi.nlm.nih.gov/articles/PMC12461986/
  97. https://www.npr.org/sections/health-shots/2023/07/26/1190085775/this-cdc-data-shows-where-rates-of-heat-related-illness-are-highest
  98. https://www.nature.com/articles/s41467-024-47197-5
  99. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01919-1/abstract
  100. https://pmc.ncbi.nlm.nih.gov/articles/PMC2900329/
  101. https://ephtracking.cdc.gov/Applications/heatTracker/
  102. https://www.kff.org/racial-equity-and-health-policy/continued-rises-in-extreme-heat-and-implications-for-health-disparities/
  103. https://www.cdc.gov/mmwr/volumes/69/wr/mm6924a1.htm
  104. https://www.cdc.gov/mmwr/volumes/73/wr/mm7315a1.htm
  105. https://journals.ametsoc.org/view/journals/wcas/13/1/wcas-d-20-0083.1.xml
  106. https://www.sccm.org/clinical-resources/guidelines/guidelines/guideline-for-the-treatment-of-heat-stroke
  107. https://journals.lww.com/ccmjournal/fulltext/2025/02000/executive_summary__society_of_critical_care.21.aspx
  108. https://www.annemergmed.com/article/S0196-0644%2824%2900407-4/fulltext
  109. https://health.mil/News/Articles/2025/06/01/MSMR-Heat-Illness-2025
  110. https://pmc.ncbi.nlm.nih.gov/articles/PMC12326802/
  111. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2824%2900465-6/fulltext
  112. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2025.1569346/full
  113. https://pmc.ncbi.nlm.nih.gov/articles/PMC10741821/
  114. https://www.utsouthwestern.edu/newsroom/articles/year-2025/july-heat-related-illnesses-children.html
  115. https://www.sciencedirect.com/science/article/abs/pii/S1555415525002004
  116. https://www.sciencedirect.com/science/article/pii/S0160412025004453
  117. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-025-24012-4
Add your contribution
Related Hubs
User Avatar
No comments yet.